Gabapentin Market Size is estimated to grow at a CAGR of 2.6% during the forecast period
The gabapentin
market was estimated to be worth USD 2.5 billion globally in
2022, and over the course of the projected period, a CAGR of 2.6% is
anticipated. The market is expanding due to a number of factors, including a
rise in the prevalence of seizures, an aging population, more government
initiatives, easier purchasing, rising disposable income, and increased funding
for R&D. The market is expanding due to an increase in the number of
neurological disorders being treated, the growing use of gabapentin in pain
management, and the increased knowledge of medical professionals regarding the
drug's potential benefits in treating neuropathic disorders. The drug's
clearance for a number of ailments encourages market growth even further.
Request
For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/gabapentin-market
Growth Drivers
The market is growing at a substantial rate due to factors
including growing health consciousness among the populace, rising disposable
income, growing knowledge of neurological illnesses, and developing
applications in pain treatment. Growth in the area is being propelled by
gabapentin's adaptability in providing effective and efficient treatment for a
range of medical disorders.
The market is expanding due to rising demand for gabapentin as a
treatment for migraines and anxiety disorders. Doctors and other medical
professionals are confidently prescribing this medication to treat a variety of
illnesses. The market for gabapentin is expanding dramatically, driven mostly
by the rising prevalence of cardiovascular illnesses and seizures. Governments
from all around the world are heavily funding research and development, which
has greatly expanded this sector. The market is expanding because to the rising
prevalence of seizures and neurological illnesses.
Segmentation
Product Type
· Capsule
· Tablet
Route of
Administration
· Oral
· Parenteral
· Intravenous
Application
· Epilepsy
· Neuropathic
pain
· Restless
Legs
Mode of Purchase
· Prescription
· Retail
· Over
the counter
Distribution
Channel
· Hospitals
· Retail
Pharmacies
· Online
Regional Outlook
· Asia
Pacific
· North
America
· Europe
· Latin
America
· Middle
East and Asia Pacific
Key Players
· Amagen
Inc
· Bristol
Myers Squibb Co.
· Erytech
Pharma
· Novartis
AG
· Pfizer
Inc
· Rare
Disease Therapeutics Inc
· Baxter
· Aurobindo
Pharma limited
· Zydus
Cadila Healthcare ltd
· Hikma
Pharmaceuticals Plc
· Dr.
Reddy’s laboratories ltd
· Mylan
N.V.
· Torrent
pharmaceuticals ltd
· Eisai
Company Limited
· Kiddis
Pharma
· OBI
Pharma
· Celgene
Corporation
· Spectrum
Pharmaceuticals
· Other
Players
For
More Information about this Report @ https://www.xresearch.biz/shop/gabapentin-market
About
Us: -
xResearch is a
market research and consulting organization that uses unique data, expert
analysis, and new technologies to create trusted intelligence on industries.
Our research is focused on delivering an informed and impartial view on
essential market data of industry, and it is primarily driven by an in-depth
study covering the following parameters: Market Sizing and Forecasting, Market
Segmentation, Competitive Analysis, Strategic Assessment and Business
Modelling.
Contact:
Company Name: xResearch
Contact Person: James Lin
Email: sales@xresearch.biz
Phone: +1 718-618-4545
Comments
Post a Comment